Ovalbumin-Derived Peptides Activate Retinoic Acid Signalling Pathways and Induce Regulatory Responses Through Toll-Like Receptor Interactions.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
20 Mar 2020
Historique:
received: 13 02 2020
revised: 03 03 2020
accepted: 17 03 2020
entrez: 5 4 2020
pubmed: 5 4 2020
medline: 23 12 2020
Statut: epublish

Résumé

This study investigates the potential of a hydrolysate of ovalbumin with pepsin (OP) to preclude Th2-type immunity by the enhancement of tolerogenic dendritic cells (DCs) and regulatory T (Treg) cells. Through Toll-like receptor (TLR) stimulation, OP enhances the retinoic acid pathway on DCs by means of the induction of aldehyde dehydrogenase enzymes and transforming growth factor beta (TGF-β), and it confers upon DC the ability to upregulate interleukin 10 (IL-10) as well as other tolerance-promoting mediators downstream of TRL signalling, such as IL-27, IL-33, Notch ligands, OX40L, and the transcription factors IRF4 and IRF8. OP-conditioned DCs induce the expansion of Foxp3+ and Tr1 cells in co-culture with CD4+ T cells. Furthermore, OP directly conditions CD4+ T cells from naïve mice, without the mediation of DCs, to express aldehyde dehydrogenase (ALDH) enzymes and, in the presence of the Th2 cytokine IL-4 and exogenous TGF-β, it enhances Foxp3 expression. It is noteworthy that, on CD4+ T cells isolated from egg-allergic mice, OP significantly enriches the levels of Foxp3+ and Foxp3+ RORγt+ CD4+ T cells. In conclusion, we show that food peptides may work, analogously to microbial-driven signals, through TLRs, to promote a tolerogenic phenotype on cells of the innate and adaptive immune system, a property that is further enhanced in the context of a Th2 cytokine-rich environment.

Identifiants

pubmed: 32245005
pii: nu12030831
doi: 10.3390/nu12030831
pmc: PMC7146383
pii:
doi:

Substances chimiques

Biomarkers 0
NF-kappa B 0
Peptide Fragments 0
Toll-Like Receptors 0
Tretinoin 5688UTC01R
Ovalbumin 9006-59-1
Aldehyde Dehydrogenase 1 Family EC 1.2.1
ALDH1A2 protein, human EC 1.2.1.36
Retinal Dehydrogenase EC 1.2.1.36

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : AGL2017-88964-R
Organisme : Ministerio de Educación, Cultura y Deporte
ID : FPU16/01974 to L.P-R

Références

Mucosal Immunol. 2013 Sep;6(5):921-30
pubmed: 23299617
J Immunol. 2013 Jun 1;190(11):5516-25
pubmed: 23630352
J Immunol. 2006 Dec 1;177(11):7579-87
pubmed: 17114427
Nat Immunol. 2008 Dec;9(12):1347-55
pubmed: 18997793
J Clin Invest. 2006 Jul;116(7):2022-32
pubmed: 16767222
Nat Immunol. 2016 May;17(5):545-55
pubmed: 27019226
J Leukoc Biol. 2010 Jun;87(6):1011-8
pubmed: 20335310
J Exp Med. 2003 Feb 17;197(4):403-11
pubmed: 12591899
J Biol Chem. 2008 May 30;283(22):14955-62
pubmed: 18400747
J Exp Med. 2009 Feb 16;206(2):343-57
pubmed: 19204112
J Immunol. 2011 Jul 1;187(1):141-50
pubmed: 21646294
Science. 2015 Aug 28;349(6251):989-93
pubmed: 26160380
Trends Immunol. 2015 Dec;36(12):802-814
pubmed: 26617322
Food Res Int. 2016 Nov;89(Pt 1):661-669
pubmed: 28460964
Immunity. 2009 Apr 17;30(4):471-2; author reply 472-3
pubmed: 19371709
Nat Immunol. 2008 Jul;9(7):769-76
pubmed: 18516037
J Immunol. 2011 Jun 1;186(11):6287-95
pubmed: 21525388
Nat Med. 2009 Apr;15(4):401-9
pubmed: 19252500
J Allergy Clin Immunol. 2013 Dec;132(6):1409-19
pubmed: 24139608
J Clin Invest. 2005 Jul;115(7):1923-33
pubmed: 15937545
Science. 2006 Nov 17;314(5802):1157-60
pubmed: 17110582
J Immunol. 2005 Dec 15;175(12):8051-9
pubmed: 16339542
J Allergy Clin Immunol. 2017 May;139(5):1608-1620.e3
pubmed: 28277274
J Exp Med. 2008 Jun 9;205(6):1381-93
pubmed: 18504307
J Exp Med. 2007 Aug 6;204(8):1775-85
pubmed: 17620362
Mol Aspects Med. 2012 Feb;33(1):63-76
pubmed: 22120429
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12204-9
pubmed: 20566854
Cell Rep. 2016 Jun 21;15(12):2809-24
pubmed: 27332875
J Immunol. 2008 May 15;180(10):6501-7
pubmed: 18453568
Immunol Res. 2009;45(1):25-36
pubmed: 19597998
Int Immunol. 2009 Apr;21(4):361-77
pubmed: 19190084
Immunity. 2016 Apr 19;44(4):860-74
pubmed: 27067057
Oncoimmunology. 2015 Mar 20;4(3):e974393
pubmed: 25949893
PLoS One. 2017 Jun 8;12(6):e0178191
pubmed: 28594834
J Immunol. 2010 Nov 15;185(10):5915-25
pubmed: 20944006
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Immunol. 2013 Sep 15;191(6):3139-51
pubmed: 23960232
Clin Exp Allergy. 2017 Oct;47(10):1342-1354
pubmed: 28763132
J Immunol. 2007 Sep 15;179(6):3504-14
pubmed: 17785784
Immunology. 2009 Apr;126(4):475-84
pubmed: 18778283
J Immunol. 2008 Apr 1;180(7):4441-50
pubmed: 18354165
Biochim Biophys Acta. 2015 Feb;1852(2):365-78
pubmed: 24807060
Immunity. 2015 Aug 18;43(2):289-303
pubmed: 26231118
Nat Commun. 2013;4:2990
pubmed: 24356538
J Exp Med. 2007 Aug 6;204(8):1757-64
pubmed: 17620361
Immunity. 2008 Nov 14;29(5):758-70
pubmed: 19006694
Nat Immunol. 2007 Dec;8(12):1380-9
pubmed: 17994022
Gastroenterology. 2011 Jul;141(1):176-85
pubmed: 21596042
J Innate Immun. 2017;9(6):609-620
pubmed: 28889122
Cytokine. 2016 Sep;85:120-2
pubmed: 27322964
Science. 2015 Aug 28;349(6251):993-7
pubmed: 26272906
J Immunol. 2012 Jan 15;188(2):864-73
pubmed: 22156348
J Immunol. 2000 Jun 1;164(11):5998-6004
pubmed: 10820283
Nature. 2014 Sep 25;513(7519):564-568
pubmed: 25043027
Cell. 2004 May 14;117(4):515-26
pubmed: 15137944
PLoS One. 2014 Oct 01;9(10):e108402
pubmed: 25271635
Eur J Immunol. 2013 Apr;43(4):882-5
pubmed: 23504674

Auteurs

Mónica Martínez-Blanco (M)

Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC-UAM), Nicolás Cabrera 9, 28049 Madrid, Spain.

Leticia Pérez-Rodríguez (L)

Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC-UAM), Nicolás Cabrera 9, 28049 Madrid, Spain.

Daniel Lozano-Ojalvo (D)

Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC-UAM), Nicolás Cabrera 9, 28049 Madrid, Spain.

Elena Molina (E)

Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC-UAM), Nicolás Cabrera 9, 28049 Madrid, Spain.

Rosina López-Fandiño (R)

Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC-UAM), Nicolás Cabrera 9, 28049 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH